Showing results (41-50 of 333) with videos related to
Sort By:
Pageof 34
Blood Cancer Discovery|October 18, 2021
Genomics, Transcriptomics, and Minimal Residual Disease Detection: The Winning Team to Guide Treatment of Acute Lymphoblastic LeukemiaHeidi Segers, Jan CoolsBlood Cancer Discovery|April 8, 2022
Txnip Enhances Fitness of Dnmt3a-Mutant Hematopoietic Stem Cells via p21Christine R Zhang, Elizabeth L Ostrander, Ostap Kukhar, et al.Blood Cancer Discovery|August 15, 2020
Mutational landscape and patterns of clonal evolution in relapsed pediatric acute lymphoblastic leukemiaEsmé Waanders, Zhaohui Gu, Stephanie M Dobson, et al.Blood Cancer Discovery|August 8, 2025
A FABulous Couple: Adding PHENotype to GENotype Improves HMA/VEN Response Prediction in AMLSimon Renders, Alexander Waclawiczek, Andreas TrumppBlood Cancer Discovery|October 17, 2025
ID2 Suppresses Multiple Myeloma Cell Proliferation by Repressing the Activity of the Transcription Factor TCF3Mariateresa Fulciniti, Yao Yao, Tommaso Perini, et al.Blood Cancer Discovery|July 16, 2025
IRF4 promotes immune evasion and shapes the tumor microenvironment in Follicular LymphomaSurendra Dasari, Kerstin Wenzl, Geoffrey M Nelson, et al.Blood Cancer Discovery|July 9, 2025
Real-World Experience with Teclistamab for Relapsed/ Refractory Multiple Myeloma from the U.S. Myeloma Immunotherapy ConsortiumBeatrice M Razzo, Shonali Midha, Andrew J Portuguese, et al.Blood Cancer Discovery|September 16, 2025
Perspectives on Newly Diagnosed Myeloma Treatment and Emerging ChallengesCyrille Touzeau, Philippe MoreauBlood Cancer Discovery|June 17, 2025
The Silence of the Lambdas: Hidden Complexities in the Evolution of Double-Hit LymphomasGalina Shevchenko, Daniel J HodsonBlood Cancer Discovery|June 17, 2025
Clinical Significance of TP53-Mutant Clonal Hematopoiesis Across DiseasesYoshiaki Usui, Mikiko Endo, Yusuke Iwasaki, et al.Pageof 34